The interplay between TP53 and mevalonate pathway in ovarian cancer

被引：0
|
作者：
Abdullah, M. I. [1 ]
Abed, M. N. [1 ]
Richardson, A. [1 ]
机构：
[1] Keele Univ, Sch Pharm, ISTM, Stoke On Trent, Staffs, England
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
22P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] TP53 and ovarian cancer
    Schuijer, M
    Berns, EMJJ
    [J]. HUMAN MUTATION, 2003, 21 (03) : 285 - 291
  • [2] TP53 MUTATIONAL ANALYSIS IN OVARIAN CANCER
    Berger, A.
    Tsibulak, I.
    Azim, S. Abdel
    Shivalingaiah, G.
    Wenzel, S. S.
    Gaugg, I.
    Fleischer, M.
    Zeimet, A.
    Fiegl, H.
    Zschocke, J.
    Marth, C.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1438 - 1438
  • [3] TP53 mutations in epithelial ovarian cancer
    Zhang, Yu
    Cao, Lan
    Daniel Nguyen
    Lu, Hua
    [J]. TRANSLATIONAL CANCER RESEARCH, 2016, 5 (06) : 650 - 663
  • [4] TP53 Mutations in Breast and Ovarian Cancer
    Silwal-Pandit, Laxmi
    Langerod, Anita
    Borresen-Dale, Anne-Lise
    [J]. COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2017, 7 (01):
  • [5] TP53 MUTATIONAL ANALYSIS IN OVARIAN CANCER
    Berger, A.
    Tsibulak, I.
    Azim, S. Abdel
    Shivalingaiah, G.
    Wenzel, S. S.
    Gaugg, I.
    Fleischer, M.
    Zeimet, A.
    Fiegl, H.
    Zschocke, J.
    Marth, C.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 264 - 264
  • [6] The Mevalonate Pathway Is a Therapeutic Target in TP53 Mutant Acute Myeloid Leukemia
    Skuli, Sarah
    Bakayoko, A'Ishah
    Wertheim, Gerald
    Riley, Owen
    Kruidenier, Marisa
    Manning, Bryan
    Salimov, Akmal
    Brake-Silla, Gisela
    Dopkin, Derek
    Xu, Jimmy
    Nee, Eva
    Mesaros, Lorelai
    Hausler, Ryan
    Lavorato, Manuela
    Ogiso, Eiko
    Falk, Marni
    Maxwell, Kara
    Skuli, Nicolas
    Mesaros, Clementina
    Carroll, Martin
    [J]. BLOOD, 2023, 142
  • [7] The interplay between mutant p53 and the mevalonate pathway
    Alejandro Parrales
    Elizabeth Thoenen
    Tomoo Iwakuma
    [J]. Cell Death & Differentiation, 2018, 25 : 460 - 470
  • [8] The interplay between mutant p53 and the mevalonate pathway
    Parrales, Alejandro
    Thoenen, Elizabeth
    Iwakuma, Tomoo
    [J]. CELL DEATH AND DIFFERENTIATION, 2018, 25 (03): : 460 - 470
  • [9] The Consequence of Oncomorphic TP53 Mutations in Ovarian Cancer
    Brachova, Pavla
    Thiel, Kristina W.
    Leslie, Kimberly K.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (09) : 19257 - 19275
  • [10] TP53 variants and susceptibility to ovarian cancer in poland
    Garcia-Closas, Montserrat
    Burdett, Laurie
    Brinton, Louise
    Lissowska, Jolanta
    Sherman, Mark
    Yeager, Meredith
    Szeszenia-Dabrowska, Neonila
    Peplonska, Beata
    Welch, Robert
    Mikolajczak, Alicja Bardin
    Zatonski, Witold
    Qi, Ying
    Chanock, Stephen
    [J]. CANCER RESEARCH, 2006, 66 (08)
12345